Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2025 10:52 ET | Source: GivBux, Inc

GivBux, Inc. Eliminates $100,000 in Convertible Debt, Strengthening Financial Position

Newport Beach, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- GivBux, Inc. (OTC: GBUX) ("GivBux" or the Company"), a publicly traded Super App and charitable giving platform, today announced the...
May 10, 2022 07:10 ET | Source: Ressources Géoméga Inc.

Géoméga reçoit 1,235 M $ de l'exercice de bons de souscription et d'autres instruments

Position financière à son meilleur pour générer des investissements records dans les applications de R&D commercialesPlus de 5,1 M $ en trésorerie et équivalents de trésorerieFacilité d'emprunt de...
May 10, 2022 07:10 ET | Source: Geomega Resources Inc.

Geomega Receives $1.235M from Exercise of Warrants and Other Instruments

Strongest ever financial position to drive record investments in commercial R&D applicationsOver $5.1M in cash and cash equivalents$3M interest-free debt facility fully available from IQ for REE...
April 19, 2022 15:15 ET | Source: The Rosen Law Firm PA

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
September 27, 2021 09:21 ET | Source: BTCS Inc.

BTCS Retires Convertible Note Early, Eliminates Potential Equity Dilution

Silver Spring, MD, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology focused company, is pleased to announce that the Company has paid...
October 01, 2020 12:30 ET | Source: Deinove

2020 Half-year results: Stronger financial position and research programs moving forward despite the international context

2020 Half-year results: Stronger financial position and research programs moving forward despite the international context Clinical program for the antibiotic candidate DNV3837 continues, with the...
November 07, 2019 07:05 ET | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates

Phase 3 “RESOLVE-1” study of lenabasum for treatment of systemic sclerosis on track for topline results in summer of 2020Systemic sclerosis is a rare autoimmune disease affecting ~200,000 people in...
February 18, 2019 12:00 ET | Source: Gate Ventures Plc

Update Announcement regarding fundraising and financial position

Gate Ventures PLCUpdate Announcement regarding fundraising and financial positionISIN Number: GB00BYX2WP92TICKER: GATEGate Ventures PLCPress ReleaseFebruary 18, 2019 Gate Ventures PLC ("Gate...